Nothing written yet for this company.
GC Biopharma Corp. (006280) received Korean approval for a phase 2/3 trial of its GC3114B flu vaccine.
| Period | 006280 | KOSPI | Difference |
|---|---|---|---|
| 1 week | -2.2% | -1.5% | -0.7% |
| 1 month | +6.3% | +5.2% | +1.2% |
| 3 months | -2.4% | -22.6% | +20.2% |
| 6 months | -8.0% | +31.3% | -39.3% |
| Year to date | -19.7% | +58.7% | -78.4% |
| 1 year | -3.3% | +108.9% | -112.2% |
Closed at 21% of the way from its 52-week low (₩113,200) to its 52-week high (₩180,300).
GC Biopharma Corp. makes prescription medicines in South Korea. It is listed on KOSPI, was founded in 1969, is based in Gyeonggi, and has revenue of a few trillion won.
| Sector | Biopharma | Employees | |
| Market | KOSPI | Founded | 1969 |
| Korean name | 녹십자 | Head office | Gyeonggi |
| Symbol | Last Price |
|---|---|
| 140410Mezzion Pharma Co., Ltd. | ₩65,000 +0.0% |
| 068760Celltrion Pharm, Inc. | ₩40,850 +0.0% |
| 007390Naturecell Co., Ltd. | ₩23,950 +0.2% |
| 950160Kolon Tissue Gene, Inc. | ₩17,100 +1.1% |
| 039200Oscotec, Inc. | ₩36,600 +1.9% |
| 069620Daewoong Pharma | ₩116,100 +1.1% |
| 290650L & C BIO Co., Ltd. | ₩47,900 -1.4% |
| 127120JS Link | ₩33,600 +12.4% |
| 475830Orum Therapeutics, Inc. | ₩55,900 +2.6% |
| 195940HK inno.N Corporation | ₩42,050 +0.7% |